BCAL Diagnostics (ASX:BDX) FCF Margin %: -6,855.81% (As of Dec. 2025)


What is BCAL Diagnostics FCF Margin %?

BCAL Diagnostics ASX:BDX +10.96% FCF Margin % is -6,855.81% as of Dec. 2025. The stock has 3 warning signs investors should review. Among 204 Medical Diagnostics & Research companies, BCAL Diagnostics ranks worse than 98.53% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. BCAL Diagnostics's Free Cash Flow for the six months ended in Dec. 2025 was A$-2.95 Mil. BCAL Diagnostics's Revenue for the six months ended in Dec. 2025 was A$0.04 Mil. Therefore, BCAL Diagnostics's FCF Margin % for the quarter that ended in Dec. 2025 was -6,855.81%.

As of today, BCAL Diagnostics's current FCF Yield % is -21.62%.

The historical rank and industry rank for BCAL Diagnostics's FCF Margin % or its related term are showing as below:

ASX:BDX' s FCF Margin % Range Over the Past 10 Years
Min: -31472.73   Med: -31472.73   Max: -15018.6
Current: -15018.6

During the past 4 years, the highest FCF Margin % of BCAL Diagnostics was -15018.60%. The lowest was -31472.73%. And the median was -31472.73%.

ASX:BDX's FCF Margin % is ranked worse than
98.53% of 204 companies
in the Medical Diagnostics & Research industry
Industry Median: -1.845 vs ASX:BDX: -15018.60

BCAL Diagnostics FCF Margin % Related Terms

BCAL Diagnostics FCF Margin % Historical Data

* Premium members only.

The historical data trend for BCAL Diagnostics's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BCAL Diagnostics FCF Margin % Chart

BCAL Diagnostics Annual Data
Trend Jun22 Jun23 Jun24 Jun25
FCF Margin %
0.00 0.00 0.00 -31,472.73

BCAL Diagnostics Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 -6,855.81

ASX:BDX vs TMO, DHR, IDXX: FCF Margin % Comparison

For the Diagnostics & Research subindustry, BCAL Diagnostics's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BCAL Diagnostics FCF Margin % vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, BCAL Diagnostics's FCF Margin % distribution charts can be found below:

* The bar in red indicates where BCAL Diagnostics's FCF Margin % falls into.


BCAL Diagnostics FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

BCAL Diagnostics's FCF Margin for the fiscal year that ended in Jun. 2025 is calculated as

FCF Margin=Free Cash Flow (A: Jun. 2025 )/Revenue (A: Jun. 2025 )
=-6.924/0.022
=-31,472.73 %

BCAL Diagnostics's FCF Margin for the quarter that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=-2.948/0.043
=-6,855.81 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of -6,855.81% mean?
BCAL Diagnostics (ASX:BDX) has a FCF Margin % of -6,855.81% as of Dec. 2025. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on BCAL Diagnostics and its competitors. According to the industry distribution chart, BCAL Diagnostics ranks #201 out of 204 companies in the Medical Diagnostics & Research industry, placing it in the top 98.5%.
Is BCAL Diagnostics' FCF Margin % too high?
BCAL Diagnostics' current FCF Margin % is -6,855.81%. Based on the distribution chart, BCAL Diagnostics ranks #201 out of 204 companies in the Medical Diagnostics & Research industry, which is in the bottom quartile relative to peers.
How does BCAL Diagnostics' FCF Margin % compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, BCAL Diagnostics ranks #201 out of 204 companies for FCF Margin %. This places BCAL Diagnostics in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Medical Diagnostics & Research company?
A good FCF Margin % depends on the Medical Diagnostics & Research industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on BCAL Diagnostics and its competitors. BCAL Diagnostics's current FCF Margin % is -6,855.81%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BCAL Diagnostics stock overvalued right now?
BCAL Diagnostics (ASX:BDX) has a current FCF Margin % of -6,855.81%. The current FCF Margin % is -6,855.81%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For BCAL Diagnostics (ASX:BDX), the current FCF Margin % is -6,855.81% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

BCAL Diagnostics Business Description

Address 50 Clarence Street, Suite 506, Level 5, Sydney, NSW, AUS, 2000
BCAL Diagnostics Ltd is a biotechnology company developing a novel blood screening test to improve the early diagnosis and monitoring of breast cancer that is safe, cost-effective, accurate, and available to all women regardless of age, race, and geographic location.